Learn about our mission, our charter and principles, and who we are.

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Visit this section to get in touch with our offices around the world.

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

Learn about how, why, and where MSF teams respond to different diseases around the world, and the challenges we face in providing treatment.

Learn about the different contexts and situations in which MSF teams respond to provide care, including war and natural disaster settings, and how and why we adapt our activities to each.

Learn about our response and our work in depth on specific themes and events.

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

Our staff “own” and manage MSF, making sure that we stay true to our mission and principles, through the MSF Associations.

We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

Read stories from our staff as they carry out their work around the world.

Hear directly from the inspirational people we help as they talk about their experiences dealing with often neglected, life-threatening diseases.

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

SAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa.

Regional logistic centre for the whole East Africa region

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

Find important research based on our field experience on our dedicated Field Research website.

The Manson Unit is a London, UK-based team of medical specialists who provide medical and technical support, and conduct research for MSF.

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

The Intersectional Benchmarking Unit collects and analyses data about local labour markets in all locations where MSF employs people.

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

Paris – Recently CE-certified, the Antibiogo application will be deployed as of this summer in several Médecins Sans Frontières (MSF) laboratories. This innovative diagnostic tool, developed and tested by the MSF Foundation to meet the needs of low- and middle-income countries (LMIC) will eventually be available in the form of a free, offline and downloadable application, and offers considerable hope for slowing down antibiotic resistance, a major public health threat.

This diagnostic tool enables non-expert laboratory technicians to measure and interpret antibiograms, the test that determines the sensitivity of bacteria to different antibiotics. This test, which is essential to help doctors prescribe the most effective antibiotics to their patients, is usually interpreted by microbiologists who are not available in LMIC.

Antimicrobial resistance (AMR), recognised by the WHO as a major public health threat, caused 1.27 million deaths in 2019. It could become the leading cause of mortality with 10 million deaths per year globally from 2050 onwards if nothing is done.

“Thanks to Antibiogo, any microbiology laboratory technician, anywhere in LMIC, will be able to read and interpret an antibiogram directly on their telephone and know the resistance profile of the bacteria responsible for patient infection, ” says Dr Nada Malou, head of the Antibiogo programme. 

“Properly used, it is a fantastic new diagnostic tool, which will help to ensure wider access to high-quality bacteriological tests even in the absence of microbiologists. This will make it possible not only to treat patients with the most appropriate antibiotics but also to reduce antibiotic resistance,” says Malou.   Furthermore, the vast majority of diagnostic tests are developed in high-income countries in line with market logic and then, once they have been made profitable, are made available to countries with limited resources without taking into account the specificity of their contexts.  “Antibiogo is innovative in that it was created based on the need identified in countries with limited resources, was developed with users in these countries and with their data, and was tested in the people who are going to benefit from it. The development model of this medical device is the reverse of the one we usually observe, and meets real needs observed in LMIC,” says Malou.  

In high-income countries, prescription of antibiotics is facilitated by the use of automated systems for reading and interpretation of antibiograms, and by the expertise of microbiologists. However, in LMIC, which do not have this expensive equipment or sufficient numbers of clinical microbiologists, identification of antibiotic resistance is much more complicated or often absent.   Antibiogo is based on image processing, artificial intelligence technology and an existing expert system. In practice, the application enables laboratory technicians to measure the inhibition diameters found on antibiograms and especially to interpret their results, without necessarily having expertise in microbiology    In the field, the results show a very high level of concordance, ranging from 90-98 per cent depending on the bacteria, when they are compared with the interpretation made by qualified microbiologists.     The Antibiogo mobile application developed by the MSF Foundation will be used first of all in MSF laboratories in Mali, the Central African Republic, Jordan and Yemen, and will subsequently be deployed more widely. In the long run, this tool is intended for healthcare professionals in all LMIC. After final certification is obtained in 2023, the application will be able to be downloaded by all microbiology laboratories in LMIC.

Your donations pay for millions of consultations, surgeries, treatments and vaccinations every year.

78 Rue de Lausanne CP 1016 1211 Geneva Switzerland Federal identification number: UID CH-660.1.555.004-1